Clinical Trial Update: Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating allogeneic mesenchymal stem cells for survivors of ischemic stroke (ASSIST) is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd. | Conditions: Ischemic Stroke | Phase 1, Phase 2 | Status: UNKNOWN